Open Sans Bold 6pt (12px)

Aleo Light 21pt (42px)

Open Sans Bold 6pt (12px)

Aleo Light Italic 33px

Open Sans 12pt (12px) Line Spacing 22px
Tanner Pharmaceuticals, Inc., a global provider of integrated specialty access solutions, announces the signing of an exclusive distribution agreement with Merz North America, a specialty healthcare company with a strong commitment to the U.S. neurosciences space.

Aleo Light 12pt (25px)
Post-clinical trials, many patients wish to continue treatment with the trial drug yet the drug may be years away from commercial availability.

Aleo 8pt (17px) Line height 25px

1. Aleo Light 49px

Open Sans Light/Semibold 23px

Aleo Light Italic 8pt (16px) Line height 25px We are excited to enter this collaboration with Tanner Pharmaceuticals to provide this important treatment to pediatric neurology patients in Latin America.”

-Glenn Block, Vice President and Head – U.S. Neurosciences for Merz North America

• Open Sans Semibold 6pt (12px)
• Lorem ipsum dolor sit amet, consectetur adipiscing elit exercitation ullamco laboris.
• Lorem ipsum dolor sit amet.

1. Open Sans 6pt (12px)
2. Money: Prevent $576M from crashes per day and save $14M in speeding tickets per day for the rest of our lives.
3. Fuel: Save 420,000 barrels of fuel (35% reduction) per day
4. There is no doubting the convenience factor. Less time in the car, more productive hours at work and home and less variability in traffic.

• Product Lifecycle
• Product Lifecycle Challenges
• Global Access Programs (GAP)

• Stories
• Global Access Program
  • Continuity of Supply
  • Pre-registration Supply
  • Post-withdrawal Supply
• About
• Contact